Bill Summary
HB 353 Sickle Cell Disease Treatment of Pain Continuing Education (2026 Session)
Robinson, F. Co Sponsors: Campbell, Hunschofsky, Maney, Bartleman CS Sponsors: Health Professions & Programs Subcommittee
Sickle Cell Disease Treatment of Pain Continuing Education: Revises requirements for continuing education course on prescribing controlled substances. Effective Date: July 1, 2026
11/05/25
HOUSE
Filed
11/12/25
HOUSE
Referred to Health Professions & Programs Subcommittee; Health & Human Services Committee
11/12/25
HOUSE
Now in Health Professions & Programs Subcommittee
02/09/26
HOUSE
On Committee agenda - Health Professions & Programs Subcommittee, 02/11/26, 9:30 am, 102 H - PCS
02/11/26
HOUSE
Favorable with CS by Health Professions & Programs Subcommittee; 15 Yeas, 0 Nays
02/11/26
HOUSE
Committee Substitute Text (C1) Filed
02/12/26
HOUSE
Now in Health & Human Services Committee
02/20/26
HOUSE
On Committee agenda - Health & Human Services Committee, 02/24/26, 3:00 pm, 17 H
02/24/26
HOUSE
Favorable by Health & Human Services Committee; 23 Yeas, 0 Nays
02/25/26
HOUSE
Placed on Calendar, on 2nd reading
03/11/26
HOUSE
Laid on Table, refer to CS/SB 844
No amendments to this bill text filed.
456.0301
Research & Reports
Revenue Estimating Coverence Reports, Veto, Transmittal letters and more. Learn more.
No reports related to this bill.
Upcoming Events
Florida's most comprehensive legislative calendar.
Learn more.
No events are scheduled at this time.
Press Releases
Related Press Announcements. Learn more.
No press releases related to this bill.
Features above are available to LobbyTools subscribers.
Request a free demo or call (850) 915-0100 ext. 2 to learn more.